Chemomab Therapeutics Ltd. Annual Net Cash Provided by (Used in) Operating Activities in USD from 2018 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
Summary
Chemomab Therapeutics Ltd. annual/quarterly Net Cash Provided by (Used in) Operating Activities history and growth rate from 2018 to 2023.
  • Chemomab Therapeutics Ltd. Net Cash Provided by (Used in) Operating Activities for the quarter ending March 31, 2023 was -$7.19M, a 93.6% decline year-over-year.
  • Chemomab Therapeutics Ltd. annual Net Cash Provided by (Used in) Operating Activities for 2023 was -$23.6M, a 15.9% decline from 2022.
  • Chemomab Therapeutics Ltd. annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$20.4M, a 64.6% decline from 2021.
  • Chemomab Therapeutics Ltd. annual Net Cash Provided by (Used in) Operating Activities for 2021 was -$12.4M, a 136% decline from 2020.
Net Cash Provided by (Used in) Operating Activities, Annual (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Annual Growth (%)
* An asterisk sign (*) next to the value indicates that the value is likely invalid.